SUPV. PHARMACOLOGIST
US Food and Drug Administration
Dr. Lanyan (Lucy) Fang currently serves as acting Deputy Director and has served as Associate Director of the Division of Quantitative Methods and Modeling (DQMM), Office of Research and Standards, since February 2019. Prior to that, she served as Team Lead of the Quantitative Clinical Pharmacology team within DQMM for 5 years. She has established herself as the FDA expert in the use of quantitative clinical pharmacology approaches in the review and regulation of generic drugs. Prior to her current position, Dr. Fang worked as senior clinical pharmacology reviewer in the FDA’s Office of Clinical Pharmacology (2009 – 2014) and senior pharmacokinetist in Merck (2007 – 2009). Dr. Fang obtained her PhD in Pharmaceutical Sciences from The Ohio State University and is a graduate of the Excellence in Government Fellows program (2014-2015).